[Immunotherapy of cancer: evolution of concepts and clinical advances]

Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association·2026

Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8+ T cells.

Molecular therapy. Nucleic acids·2026

Emerging biomarkers of immune checkpoint inhibitor toxicity in triple-negative breast cancer: a mini-review.

Frontiers in immunology·2026

Durable immunovirological control after sequential mogamulizumab and tucidinostat in relapsed or refractory adult T-cell leukemia/lymphoma.

Frontiers in immunology·2026

Generation of an NG2 targeting bispecific antibody for the induction of T-cell immunity against melanoma.

Journal of translational medicine·2026

Differential peripheral immune dynamics underlie therapeutic response to chemotherapy and chemoimmunotherapy in triple-negative breast cancer.

ImmunoHorizons·2026

Related Experiment Videos

[Immunotherapy of cancer: evolution of concepts and clinical advances]

Related Concept Videos

T-cell subsets in tumour rejection responses.

The immunobiology ofvitamin D William F.C. Rigby.

Toxicity of fatty acid salts to German and American cockroaches.

Regulation of the contact sensitivity response to urushiol with anti-urushiol monoclonal antibody ALG 991.

Measurement of murine IgE antibody responses to dust mite allergens by in vitro assay.

A phase II study of effect of addition of trichosanthin to zidovudine in patients with HIV disease and failing antiretroviral agents.

[In utero treatment of twin-to-twin transfusion syndrome].

[In utero treatment of spina bifida].

[Syphilis and pregnancy].

[Second-line treatments for Parkinson's disease].

[Ageism in healthcare: sad prejudices!]

[Vaccination for pregnant women].

Computed tomographic Characteristics of Presumed Normal Canine Iliosacral Lymph Nodes.

Novel lipid nanoparticle in a mRNA cancer vaccine drives tumor control via type I IFNs and effector CD8+ T cells.

Emerging biomarkers of immune checkpoint inhibitor toxicity in triple-negative breast cancer: a mini-review.

Durable immunovirological control after sequential mogamulizumab and tucidinostat in relapsed or refractory adult T-cell leukemia/lymphoma.

Generation of an NG2 targeting bispecific antibody for the induction of T-cell immunity against melanoma.

Differential peripheral immune dynamics underlie therapeutic response to chemotherapy and chemoimmunotherapy in triple-negative breast cancer.

Related Experiment Videos

[Immunotherapy of cancer: evolution of concepts and clinical advances]

Related Concept Videos

Related Articles